Membrane transport as a determinant of the hepatic elimination of drugs and metabolites

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 10-11, 1996, Pages 970-974

  Evans, Allan M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Drug; Hepatocyte; Liver; Membrane transport; Metabolite; Pharmacokinetics

Indexed keywords

DRUG METABOLITE; ENALAPRIL; MORPHINE;

CONFERENCE PAPER; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; LIVER CELL; LIVER FUNCTION; MEMBRANE TRANSPORT;

EID: 0029844902     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb01151.x     Document Type: Conference Paper

References (32)

1. Groothuis GMM, Meijer DKF. Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs. Enzyme 1992; 46: 94-138.
2. Tiribelli C. Determinants in the hepatic uptake of organic anions. J. Hepatol. 1992; 14: 385-90.
3. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds: Molecular mechanisms of membrane transport. Biochim. Biophys. Acta 1995; 1241: 215-68.
4. Oude Elferink RPJ, Jansen PLM. The role of the canalicular multispecific organic anion transporter in the disposal of endo-and xenobiotics. Pharmacol. Ther. 1994; 64: 77-97.
5. Vore M. Regulation of drug conjugate processing by hepatocellular transport systems. In: Kauffman FC (ed.). Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Springer-Verlag, Berlin. 1994; Ch. 11.
6. Goresky CA, Schwab AJ. Flow, cell entry, and metabolic disposal: Their interactions in hepatic uptake. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (eds). The Liver: Biology and Pathobiology. Raven Press, New York. 1988; Ch. 46.
7. Goresky CA, Schwab AJ, Pang KS. Kinetic models of hepatic transport at the organ level. In: Tavoloni N, Berk PD (eds). Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. Raven Press, New York. 1993; Ch. 2.
8. Weisiger RA. Dissociation from albumin: A potentially rate-limiting step in the clearance of substances by the liver. Proc. Natl Acad. Sci. USA 1987; 82: 1563-7.
9. Meijer DKF, van der Sluijs P. Covalent and noncovalent protein binding of drugs: Implications for hepatic clearance, storage, and cell-specific drug delivery. Pharm. Res. 1989; 6: 105-18.
10. Rowland M, Evans AM. Physiologic models of hepatic drug elimination. In: Rescigno A, Thakur AK (eds). New Trends in Pharmacokinetics. Plenum Press, New York. 1991; pp. 83-102.
11. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol. Rev. 1987; 39: 1-47.
12. Lee H-J, Chiou WL. Erythrocytes as barriers for drug elimination in the isolated rat liver. I. Doxorubicin. Pharm. Res. 1989; 6: 833-9.
13. Lee H-J, Chiou WL. Erythrocytes as barriers for drug elimination in the isolated rat liver. II. Propranolol. Pharm. Res. 1989; 6: 840-5.
14. Pang KS, Barker F, Simard A, Schwab AJ, Goresky CA. Sulfation of acetaminophen by the perfused rat liver: The effect of red blood cell carriage. Hepatology 1995; 22: 267-82.
15. Wattiaux R, Jadot M, Dubois F, Misquith S, Wattiaux-der Coninck S. Uptake of exogenous DNA by rat liver: Effect of cationic lipids. Biochem. Biophys. Res. Commun. 1995; 213: 81-7.
16. Meijer DKF, Mol WEM, Müller M, Kurz G. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J. Pharmacokinet. Biopharm. 1990; 18: 35-70.
17. Sathirakul K, Suzuki H, Yasuda K, Hanano M, Sugiyama Y. Construction of a physiologically based pharmacokinetic model to describe the hepatobiliary excretion process: Quantitative estimation of intracellular diffusion. Biol. Pharm. Bull. 1993; 16: 273-9.
18. Crawford JM, Gollan JL. Transcellular transport of organic anions in hepatocytes: Still a long way to go. Hepatology 1991; 14: 192-7.
19. McPhail ME, Knowles RG, Salter M, Dawson J, Burchell B, Pogson CI. Uptake of acetaminophen (paracetamol) by isolated rat liver cells. Biochem. Pharmacol. 1993; 45: 1599-604.
20. Iwamoto K, Eaton DL, Klaassen CD. Uptake of morphine and nalorphine by isolated rat hepatocytes. J. Pharmacol. Exp. Ther. 1978; 206: 181-9.
21. de Lannoy IAM, Pang KS. Effect of diffusional barriers on drug and metabolite kinetics. Drug Metab. Dispos. 1987; 15: 51-8.
22. Taylor CP, Vartanian MG. Probenecid pretreatment enhances anticonvulsant action of NBQX in mice. Eur. J. Pharmacol. 1992; 213: 151-3.
23. Dalgaard L, Hjortkjfr RK, Regnier B, Nordholm L. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(F)quinoxalone-2,3-dione) in mice, rats, and dogs. Interactions with probenecid. Drug Metab. Dispos. 1994; 22: 289-93.
24. de Lannoy IAM, Barker F, Pang KS. Formed and preformed metabolite excretion clearances in the liver, a metabolite formation organ: Studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver. J. Pharmacokinet. Biopharm. 1993; 21: 395-422.
25. Evans AM, Shanahan K. Biliary excretion of hepatically generated and pre-formed morphine-3-glucuronide (M3G) in the isolated perfused rat liver: Evidence for a diffusional barrier. Clin. Exp. Pharmacol. Physiol. 1993; 20(Suppl. 1): S22.
26. Gessner T, Hamada N. High biliary and systemic excretion of a glucuronide during its hepatic synthesis. Life Sciences 1974; 15: 83-94.
27. Watari N, Iwai M, Kaneniwa N. Pharmacokinetic study of the fate of acetaminophen and its conjugates in rats. J. Pharmacokinet. Biopharm. 1983; 11: 245-72.
28. Xu X, Schwab AJ, Barker F, Goresky CA, Pang KS. Salicylamide sulfate cell entry in perfused rat liver: A multiple-indicator dilution study. Hepatology 1994; 19: 229-44.
29. Studenberg SD, Brouwer KLR. Hepatic disposition of acetaminophen and metabolites. Pharmacokinetic modelling, protein binding and subcellular distribution. Biochem. Pharmacol. 1993; 46: 739-46.
30. de Vries MH, Groothuis GMM, Mulder GJ, Nguyen H, Meijer DKF. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism. Biochem. Pharmacol. 1985; 34: 2129-35.
31. Ratna S, Chiba M, Brandyopadhyay L, Pang KS. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver. Hepatotogy 1993; 17: 838-53.
32. Kauffman FC. Regulation of drug conjugate production by futile cycling in intact cells. In: Kauffman FC (ed.). Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity. Springer-Verlag, Berlin. 1994; Ch. 9.